Table: Takara Bio -2019/20 group results

Takara Bio

14/05/2020 07:00

May 14 (Reuters)- 
          Takara Bio Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           34.57           35.84          33.80         14.37    
               (-3.6 pct)      (+10.9 pct)    (-2.2 pct)    (-12.7 pct) 
  Operating        6.27            5.46           4.50        619 mln   
               (+14.8 pct)     (+53.7 pct)    (-28.3 pct)   (-79.6 pct) 
  Recurring        6.35            5.67           4.60        693 mln   
               (+12.1 pct)     (+46.7 pct)    (-27.5 pct)   (-76.6 pct) 
  Net
  Net              3.82            3.66           2.60                  
               (+4.4 pct)      (+56.6 pct)    (-31.9 pct)  (-100.0 pct) 
  EPS           31.72 yen       30.38 yen      21.59 yen        NIL     
  Ann Div       8.00 yen        7.00 yen       8.00 yen                 
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div       8.00 yen        7.00 yen       8.00 yen                 
  
  NOTE - Takara Bio Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T